Increased serum MMP-3 in severe asthma is associated with oral steroid use; data from U-BIOPRED and BIOAIR cohorts

R. Knowles (Stevenage, United Kingdom)

Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Session: "Alarming" immunological patterns in asthma
Session type: Poster Discussion
Number: 580
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Knowles (Stevenage, United Kingdom). Increased serum MMP-3 in severe asthma is associated with oral steroid use; data from U-BIOPRED and BIOAIR cohorts. 580

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Plasma protein profiles as markers of asthma severity and exposure to oral corticosteroids in U-BIOPRED and BIOAIR
Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma
Year: 2020




Free serum IL-18 levels and responsiveness to omalizumab in patients with severe asthma
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016

Oral corticosteroid treatment reduces serum chitotriosidase activity in patients with COPD
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015


Comparable serum periostin levels among a Japanese population with asthma, COPD, and asthma-COPD overlap
Source: International Congress 2017 – Many faces of asthma assessment
Year: 2017



Measures of adherence in patients with severe asthma prescribed systemic steroids in the U-BIOPRED cohort
Source: International Congress 2018 – Clinical markers of asthma
Year: 2018


Simultaneously increased serum periostin and urinary EDN relates to reduced lung function in adults with asthma from the Swedish GA2LEN study
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016

Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015

Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020


Baseline data and responses to oral steroid intervention in asthma and COPD: interim report from the BIOAIR EU study
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007



Oral corticosteroid use in Swedish and Finnish severe asthma patients
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019


Elevated circulating MMP-9 is associated with increased exacerbation risk in COPD: results from SPIROMICS and COPDGene
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018



Prevalence of oral corticosteroid use in the German severe asthma population
Source: ERJ Open Res, 5 (4) 00092-2019; 10.1183/23120541.00092-2019
Year: 2019



Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
Source: Eur Respir J, 59 (2) 2100142; 10.1183/13993003.00142-2021
Year: 2022



Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 284s
Year: 2005

Cytokines and MMP-9 level in serum and induced sputum of patients with suspicion of occupational COPD
Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods
Year: 2016

Serum periostin in healthy controls and patients with asthma and chronic rhinosinusitis; data from the Swedish GA(2)LEN population study
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016

Serum levels of IL-6 in adult patients with moderate to severe asthma.
Source: International Congress 2017 – Novel mechanisms in asthma
Year: 2017


The new approaches to the oral corticosteroid dosage decrease in patients with severe steroid-resistant bronchial asthma
Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Year: 2005


Effect of urbanisation on the relationship between total serum IgE and asthma
Source: Eur Respir J 2013; 41: 1074-1081
Year: 2013